Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Colonic Neoplasms × XELOX × Clear all

Phase

Status

Unknown 6 Recruiting 3 Terminated 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 11 Stomach Neoplasms 4 Rectal Neoplasms 4 Neoplasms 1 Neoplasm Metastasis 1 Locally Advanced Rectal Cancer 1 Colonic Neoplasms 1 Colonic Diseases 1

Interventions

Fluorouracil 105 Leucovorin 99 Oxaliplatin 85 Irinotecan 75 Bevacizumab 44 Cetuximab 34 Capecitabine 33 Folfox protocol 27 Panitumumab 17 Colonoscopy 15 Chemotherapy, Adjuvant 15 Floxuridine 14 Early Intervention, Educational 12 Erlotinib Hydrochloride 11 Surveys and Questionnaires 10 IFL protocol 10 Immunohistochemistry 9 Counseling 9 Methods 8 Gemcitabine 8 Exercise 8 Dexamethasone 8 Psychiatric Rehabilitation 7 Celecoxib 7 Blood Specimen Collection 7 sargramostim 6 Radiotherapy 6 Nivolumab 6 Melphalan 6 Gene Expression Profiling 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03565029 2024-12-27

NO-CUT

Niguarda Hospital

Phase 2 Completed

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡